CHAMPAIGN, Ill. -- Monitoring the progression of multiple sclerosis-related gait issues can be challenging in adults over 50 years old, requiring a clinician to differentiate between problems related ...

The FDA authorized marketing of the Portable Neuromodulation Stimulator (Pons) for short-term treatment of gait issues arising from mild to moderate symptoms associated with multiple sclerosis (MS) ...

A recent study looked to improve the monitoring of treatments for patients with multiple sclerosis (MS) by quantifying gait characteristics and gait deficits in laboratory and daily life conditions. A ...

PoNS is a portable, noninvasive, prescription-only device intended to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and older. The Food and Drug ...

Researchers at the University of North Carolina School of Medicine found that falls simulated through virtual reality could enable early detection of balance problems in patients with multiple ...

The US Food and Drug Administration (FDA) has approved the Portable Neuromodulation Stimulator (PoNS, Helius Medical Inc) for the short-term treatment of walking impairments as a result of mild to ...

Could a new device called a portable neuromodulation stimulator (PoNS) help improve your mobility and balance with multiple sclerosis? PoNS is a device that delivers mild electrical pulses to two ...

People with multiple sclerosis (MS) often have a greatly increased risk of falling and injuring themselves even when they feel they're able to walk normally. Now a team led by scientists from the UNC ...

People with multiple sclerosis (MS) often have a greatly increased risk of falling and injuring themselves even when they feel they're able to walk normally. Now a team has demonstrated what could be ...

Multiple sclerosis (MS) affects the central nervous system and can cause indirect joint pain by affecting your muscles, balance, and energy levels. Multiple sclerosis (MS) is a progressive condition ...

Researchers have created an assessment to identify MS patients who have cognitive impairment but few mobility issues, a newly recognized MS subtype.